Investigation of plasma biomarkers in HIV-1/HCV mono- and coinfected individuals by multiplex iTRAQ quantitative proteomics

OMICS A Journal of Integrative Biology

Volumn 15, Issue 10, 2011, Pages 705-717

  Shetty, Vivekananda ^a   Jain, Pooja ^b   Nickens, Zacharie ^a   Sinnathamby, Gomathinayagam ^a   Mehta, Anand ^b   Philip, Ramila ^a  

^a Immunotope Inc   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A2; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; BIOLOGICAL MARKER; GLYCOPROTEIN; HISTIDINE; PLASMA PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; FEMALE; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLAMMATION; LIPID METABOLISM; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MIXED INFECTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; UPREGULATION;

AMINO ACID SEQUENCE; BIOLOGICAL MARKERS; BLOOD PROTEINS; CASE-CONTROL STUDIES; COINFECTION; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEOLYSIS; PROTEOMICS; TANDEM MASS SPECTROMETRY; UP-REGULATION;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80053995029     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2011.0004     Document Type: Article

References (51)

1. Attallah, A.M., Zahran, F., Ismail, H., Omran, M.M., El-Dosoky, I., and Shiha, G.E. (2007). Immunochemical identification and detection of serum fibronectin in liver fibrosis patients with chronic hepatitis C. J Immunoassay Immunochem 28, 331-342. (Pubitemid 47450892)
2. Baeten, J.M., Wener, M.H., Bankson, D.D., Lavreys, L., Richardson, B.A., Mandaliya, K., et al. (2006). HIV-1 infection alters the retinol-binding protein:transthyretin ratio even in the absence of the acute phase response. J Nutr 136, 1624-1629. (Pubitemid 43765372)
3. Bard, J.M., Lassalle, R., Capeau, J., Bach-Ngohou, K., Nazih- Sanderson, F., Remy, G., et al. (2006). Association of apolipoproteins C3 and E with metabolic changes in HIV-infected adults treated with a protease-inhibitor- containing antiretroviral therapy. Antivir Ther 11, 361-370. (Pubitemid 43823555)
4. Bruder, C., Hagleitner, M., Darlington, G., Mohsenipour, I., Wurzner, R., Hollmuller, I., et al. (2004). HIV-1 induces complement factor C3 synthesis in astrocytes and neurons by modulation of promoter activity. Mol Immunol 40, 949-961. (Pubitemid 38077039)
5. Burgener, A., Boutilier, J., Wachihi, C., Kimani, J., Carpenter, M., Westmacott, G., et al. (2008). Identification of differentially expressed proteins in the cervical mucosa of HIV-1-resistant sex workers. J Proteome Res 7, 4446-4454.
6. Chen, D.S., Sung, J.L., Sheu, J.C., Lai, M.Y., How, S.W., Hsu, H.C., et al. (1984). Serum alpha-fetoprotein in the early stageof human hepatocellular arcinoma. Gastroenterology 86, 1404-1409. (Pubitemid 14147930)
7. Cheung, K.J., Tilleman, K., Deforce, D., Colle, I., and Van Vlierberghe, H. (2009). The HCV serum proteome: a search for fibrosis protein markers. J Viral Hepat 16, 418-429.
8. Domitrovich, A.M., Felmlee, D.J., and Siddiqui, A. (2005). Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion. J Biol Chem 280, 39802-39808. (Pubitemid 41779113)
9. Dumestre-Perard, C., Ponard, D., Drouet, C., Leroy, V., Zarski, J.P., Dutertre, N., et al. (2002). Complement C4 monitoring in the follow-up of chronic hepatitis C treatment. Clin Exp Immunol 127, 131-136. (Pubitemid 34155468)
10. Dwivedi, R.C., Krokhin, O.V., Cortens, J.P., and Wilkins, J.A. (2010). Assessment of the reproducibility of random hexapeptide peptide library-based protein normalization. J Proteome Res 9, 1144-1149.
11. Ernoult, E., Bourreau, A., Gamelin, E., and Guette, C. (2010). A proteomic approach for plasma biomarker discovery with iTRAQ labelling and OFFGEL fractionation. J Biomed Biotechnol 2010, 927917.
12. Franciscus, A., and Highleyman, L. (2007). HIV/HCV Coinfection. In Hepatitis C Support, pp. Factsheet: 2. HCVadvocate.org, San Francisco, CA.
13. Gangadharan, B., Antrobus, R., Dwek, R.A., and Zitzmann, N. (2007). Novel serum biomarker candidates for liver fibrosis in hepatitis C patients. Clin Chem 53, 1792-1799. (Pubitemid 47509672)
14. Garcia-Garcia, J., Gonzalez-Escoda, E., Navarro-Lopez, V., Hernandez-Lorido, R., Gregori-Colome, J., and Mola-Caballero de Rodas, S. (2006). [Persistent neutrophilic meningitis]. Rev Neurol 43, 702-703.
15. Gonzalez, S.A., and Talal, A.H. (2003). Hepatitis C virus in human immunodeficiency virus-infected individuals: an emerging comorbidity with significant implications. Semin Liver Dis 23, 149-166. (Pubitemid 36666684)
16. Guerrier, L., Righetti, P.G., and Boschetti, E. (2008). Reduction of dynamic protein concentration range of biological extracts for the discovery of low-abundance proteins by means of hexapeptide ligand library. Nat Protoc 3, 883-890. (Pubitemid 351639032)
17. Hartwig, S., Czibere, A., Kotzka, J., Passlack, W., Haas, R., Eckel, J., et al. (2009). Combinatorial hexapeptide ligand libraries (Proteo- Miner): an innovative fractionation tool for differential quantitative clinical proteomics. Arch Physiol Biochem 115, 155-160.
18. Harvey, S.B., Zhang, Y., Wilson-Grady, J., Monkkonen, T., Nelsestuen, G.L., Kasthuri, R.S., et al. (2009). O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease. J Proteome Res 8, 603-612.
19. Heckmann, J.G., Kayser, C., Heuss, D., Manger, B., Blum, H.E., and Neundorfer, B. (1999). Neurological manifestations of chronic hepatitis C. J Neurol 246, 486-491. (Pubitemid 29326845)
20. Imbert-Bismut, F., Ratziu, V., Pieroni, L., Charoltte, F., Benhamou, Y., and Poynard, T. (2001). Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357, 1069-1075. (Pubitemid 32322537)
21. Keidel, E.M., Ribitsch, D., and Lottspeich, F. (2010). Equalizer technology-equal rights for disparate beads. Proteomics 10, 2089-2098.
22. Kim, S.S., Kim, M.H., Shin, B.K., Na, H.J., Choi, J.Y., Kee, M.K., et al. (2007). Different isoforms of apolipoprotein AI present heterologous post-translational expression in HIV infected patients. J Proteome Res 6, 180-184.
23. Koike, K. (2005). Hepatitis C as a metabolic disease: implication for the pathogenesis of NASH. Hepatol Res 33, 145-150. (Pubitemid 41799793)
24. Kramer, J.R., Giordano, T.P., Souchek, J., Richardson, P., Hwang, L.Y., and El-Serag, H.B. (2005). The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C. Am J Gastroenterol 100, 56-63. (Pubitemid 41623269)
25. Kuhlmann, I., Minihane, A.M., Huebbe, P., Nebel, A., and Rimbach, G. (2010). Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review. Lipids Health Dis 9, 8.
26. Kulkarni, Y.M., Suarez, V., and Klinke, D.J., 2nd (2010). Inferring predominant pathways in cellular models of breast cancer using limited sample proteomic profiling. BMC Cancer 10, 291.
27. Lee, I.N., Chen, C.H., Sheu, J.C., Lee, H.S., Huang, G.T., Chen, D.S., et al. (2006). Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCVrelated hepatocellular carcinoma using a proteomics approach. Proteomics 6, 2865-2873.
28. Liu, L., Zeng, M., and Stamler, J.S. (1999). Hemoglobin induction in mouse macrophages. Proc Natl Acad Sci USA 96, 6643-6647. (Pubitemid 29274936)
29. Luciano-Montalvo, C., Ciborowski, P., Duan, F., Gendelman, H.E., and Melendez, L.M. (2008). Proteomic analyses associate cystatin B with restricted HIV-1 replication in placental macrophages. Placenta 29, 1016-1023.
30. Martin, I., Dubois, M.C., Saermark, T., and Ruysschaert, J.M. (1992). Apolipoprotein A-1 interacts with the N-terminal fusogenic domains of SIV (simian immunodeficiency virus) GP32 and HIV (human immunodeficiency virus) GP41: implications in viral entry. Biochem Biophys Res Commun 186, 95-101.
31. Mas, V.R., Maluf, D.G., Archer, K.J., Yanek, K., Bornstein, K., and Fisher, R.A. (2009). Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation. Transplantation 87, 143-152.
32. Matthews, G.V., and Dore, G.J. (2008). HIV and hepatitis C coinfection. J Gastroenterol Hepatol 23, 1000-1008. (Pubitemid 352019390)
33. Merchante, N., Giron-Gonzalez, J.A., Gonzalez-Serrano, M., Torre-Cisneros, J., Garcia-Garcia, J.A., Arizcorreta, A., et al. (2006). Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS 20, 49-57. (Pubitemid 41818114)
34. Meunier, J.C., Russell, R.S., Engle, R.E., Faulk, K.N., Purcell, R.H., and Emerson, S.U. (2008). Apolipoprotein c1 association with hepatitis C virus. J Virol 82, 9647-9656.
35. Ostapowicz, G., Watson, K.J., Locarnini, S.A., and Desmond, P.V. (1998). Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology 27, 1730-1735. (Pubitemid 28264702)
36. Pal, S., and Schnapp, L.M. (2004). HIV-infected lymphocytes regulate fibronectin synthesis by TGF beta 1 secretion. J Immunol 172, 3189-3195. (Pubitemid 38263710)
37. Pineda, J.A., Romero-Gomez, M., Diaz-Garcia, F., Giron- Gonzalez, J.A., Montero, J.L., Torre-Cisneros, J., et al. (2005). HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology 41, 779-789. (Pubitemid 40462940)
38. Pinter, C., Siccardi, A.G., Longhi, R., and Clivio, A. (1995). Direct interaction of complement factor H with the C1 domain of HIV type 1 glycoprotein 120. AIDS Res Hum Retroviruses 11, 577-588.
39. Rahman, S., Connolly, J.E., Manuel, S.L., Chehimi, J., Montaner, L.J. and Jain, P. (2011). Unique cytokine/chemokine signatures for HIV-1 and HCV mono-infection versus co-infection as determined by the Luminex analyses. J Clin Cell Immunol (in press).
40. Rasheed, S., Yan, J.S., Hussain, A., and Lai, B. (2009). Proteomic characterization of HIV-modulated membrane receptors, kinases and signaling proteins involved in novel angiogenic pathways. J Transl Med 7, 75.
41. Roe, B., Coughlan, S., Hassan, J., Grogan, A., Farrell, G., Norris, S., et al. (2007). Elevated serum levels of interferon- gamma - inducible protein-10 in patients coinfected with hepatitis C virus and HIV. J Infect Dis 196, 1053-1057. (Pubitemid 47580300)
42. Rosenberg, W.M., Voelker, M., Thiel, R., Becka, M., Burt, A., Schuppan, D., et al. (2004). Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 127, 1704-1713. (Pubitemid 39575849)
43. Ross, P.L., Huang, Y.N., Marchese, J.N., Williamson, B., Parker, K., Hattan, S., et al. (2004). Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3, 1154-1169.
44. Rozek, W., Ricardo-Dukelow, M., Holloway, S., Gendelman, H.E., Wojna, V., Melendez, L.M., et al. (2007). Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment. J Proteome Res 6, 4189-4199. (Pubitemid 350158497)
45. Sumida, Y., Nakashima, T., Yoh, T., Nakajima, Y., Ishikawa, H., Mitsuyoshi, H., et al. (2000). Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. J Hepatol 33, 616-622.
46. Suzman, D.L., McLaughlin, M., Hu, Z., Kleiner, D.E., Wood, B., Lempicki, R.A., et al. (2008). Identification of novel markers for liver fibrosis in HIV/hepatitis C virus coinfected individuals using genomics-based approach. AIDS 22, 1433-1439.
47. Tacnet-Delorme, P., Boyer, V., Thielens, N.M., Hernandez, J.F., Bally, I., Sim, R.B., et al. (1999). In vitro analysis of complementdependent HIV-1 cell infection using a model system. J Immunol 162, 4088-4093. (Pubitemid 29314792)
48. Toulon, P. (1998). [Hemostasis and human immunodeficiency virus (HIV) infection]. Ann Biol Clin (Paris) 56, 153-160. (Pubitemid 28165101)
49. Wiederin, J., Rozek, W., Duan, F., and Ciborowski, P. (2009). Biomarkers of HIV-1 associated dementia: proteomic investigation of sera. Proteome Sci 7, 8.
50. Ye, H., Sun, L., Huang, X., Zhang, P., and Zhao, X. (2010). A proteomic approach for plasma biomarker discovery with 8- plex iTRAQ labeling and SCX-LC-MS/MS. Mol Cell Biochem 343, 91-99.
51. Zhang, L., Jia, X., Zhang, X., Sun, J., Peng, X., Qi, T., et al. (2010). Proteomic analysis of PBMCs: characterization of potential HIV-associated proteins. Proteome Sci 8, 12.